Tirzepatide (Mounjaro) KwikPen 2.5 mg
Tirzepatide (Mounjaro) KwikPen 2.5 mg
Mounjaro KwikPen contains tirzepatide, a prescription medicine administered by subcutaneous injection. The 2.5 mg strength is typically used as the starting dose when initiating tirzepatide treatment, with dose adjustments made by a qualified healthcare professional based on the individual patient.
Tirzepatide works on GIP and GLP-1 receptors and is used alongside diet and exercise to help improve blood sugar control in adults with type 2 diabetes. It may also be prescribed for weight management depending on the specific product, indication, and local regulatory approval.
Important: Prescription use only. Use tirzepatide only under the direction of a qualified healthcare professional. Read the official product information for contraindications, warnings, storage requirements, and possible side effects. Do not use if the product has been improperly stored, damaged, or is suspected to be counterfeit.